Prior infection of chickens with H1N1 avian influenza virus elicits heterologous protection against highly pathogenic H5N2

Vaccine

Volumn 30, Issue 50, 2012, Pages 7187-7192

  Nfon, Charles ^a   Berhane, Yohannes ^a,b   Pasick, John ^a   Kobinger, Gary ^b,c   Kobasa, Darwyn ^b,c   Babiuk, Shawn ^a,b  

^a CANADIAN FOOD INSPECTION AGENCY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Heterologous immunity; Highly pathogenic avian influenza; Low pathogenic avian influenza; Natural infection; Neutralizing antibodies

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; AVIAN INFLUENZA; CELL PROLIFERATION; CELLULAR IMMUNITY; CHICKEN; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H5N2; INNATE IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SURVIVAL; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL PROLIFERATION; CHICKENS; CROSS PROTECTION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; POULTRY DISEASES; VACCINATION; VIRUS SHEDDING;

EID: 84869884400     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.021     Document Type: Article

References (35)

1. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992, 56(March (1)):152-179.
2. Olsen B., Munster V.J., Wallensten A., Waldenstrom J., Osterhaus A.D., Fouchier R.A. Global patterns of influenza A virus in wild birds. Science (New York, NY) 2006, 312(April (5772)):384-388.
3. Pasick J., Handel K., Robinson J., Copps J., Ridd D., Hills K., et al. Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia. J Gen Virol 2005, 86(March (Pt 3)):727-731.
4. Suarez D.L., Senne D.A. Sequence analysis of related low-pathogenic and highly pathogenic H5N2 avian influenza isolates from United States live bird markets and poultry farms from 1983 to 1989. Avian Dis 2000, 44(April-June (2)):356-364.
5. Suarez D.L., Perdue M.L., Cox N., Rowe T., Bender C., Huang J., et al. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol 1998, 72(August (8)):6678-6688.
6. Shortridge K.F., Zhou N.N., Guan Y., Gao P., Ito T., Kawaoka Y., et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 1998, 252(December (2)):331-342.
7. Claas E.C., de Jong J.C., van Beek R., Rimmelzwaan G.F., Osterhaus A.D. Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine 1998, 16(May-June (9-10)):977-978.
8. Buxton Bridges C., Katz J.M., Seto W.H., Chan P.K., Tsang D., Ho W., et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000, 181(January (1)):344-348.
9. Butler D. Portrait of a year-old pandemic. Nature 2010, 464(April (7292)):1112-1113.
10. Patel A., Tran K., Gray M., Li Y., Ao Z., Yao X., et al. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses. Vaccine 2009, 27(May (23)):3083-3089.
11. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006, 80(February (4)):1959-1964.
12. Masic A., Booth J.S., Mutwiri G.K., Babiuk L.A., Zhou Y. Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs. J Virol 2009, 83(October (19)):10198-10210.
13. Bodewes R., Kreijtz J.H., Geelhoed-Mieras M.M., van Amerongen G., Verburgh R.J., van Trierum S.E., et al. Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J Virol 2011, 85(March (6)):2695-2702.
14. Van Reeth K., Braeckmans D., Cox E., Van Borm S., van den Berg T., Goddeeris B., et al. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. Vaccine 2009, 27(October (45)):6330-6339.
15. Berhane Y., Leith M., Embury-Hyatt C., Neufeld J., Babiuk S., Hisanaga T. Studying possible cross-protection of Canada geese preexposed to North American low pathogenicity avian influenza virus strains (H3N8, H4N6, and H5N2) against an H5N1 highly pathogenic avian influenza challenge. Avian Dis 2010, 54(March (1 Suppl.)):548-554.
16. Costa T.P., Brown J.D., Howerth E.W., Stallknecht D.E., Swayne D.E. Homo- and heterosubtypic low pathogenic avian influenza exposure on H5N1 highly pathogenic avian influenza virus infection in wood ducks (Aix sponsa). PLoS One 2011, 6(1):e15987.
17. Fereidouni S.R., Starick E., Beer M., Wilking H., Kalthoff D., Grund C., et al. Highly pathogenic avian influenza virus infection of mallards with homo- and heterosubtypic immunity induced by low pathogenic avian influenza viruses. PLoS One 2009, 4(8):e6706.
18. Kalthoff D., Breithaupt A., Teifke J.P., Globig A., Harder T., Mettenleiter T.C., et al. Highly pathogenic avian influenza virus (H5N1) in experimentally infected adult mute swans. Emerg Infect Dis 2008, 14(August (8)):1267-1270.
19. Seo S.H., Webster R.G. Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol 2001, 75(March (6)):2516-2525.
20. OIE Office International des Epizooties manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees) 2009, p. 465-81.
21. Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 2002, 40(September (9)):3256-3260.
22. Pederson J. Avian influenza virus. Methods in molecular biology 2008, 436:67-75.
23. Zhou E.M., Chan M., Heckert R.A., Riva J., Cantin M.F. Evaluation of a competitive ELISA for detection of antibodies against avian influenza virus nucleoprotein. Avian Dis 1998, 42(July-September (3)):517-522.
24. Dalgaard T.S., Norup L.R., Pedersen A.R., Handberg K.J., Jorgensen P.H., Juul-Madsen H.R. Flow cytometric assessment of chicken T cell-mediated immune responses after Newcastle disease virus vaccination and challenge. Vaccine 2011, 28(June (28)):4506-4514.
25. Kaminski D.A., Lee F.E. Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design. Front Immunol 2011, 2:76.
26. O'Neill E., Krauss S.L., Riberdy J.M., Webster R.G., Woodland D.L. Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice. J Gen Virol 2000, 81(Nov (Pt 11)):2689-2696.
27. Kapczynski D.R., Liljebjelke K., Kulkarni G., Hunt H., Jiang H.J., Petkov D. Cross reactive cellular immune responses in chickens previously exposed to low pathogenic avian influenza. BMC Proc 2011, 5(Suppl. 4):S13.
28. Sridhar S., Begom S., Bermingham A., Ziegler T., Roberts K.L., Barclay W.S., et al. Predominance of heterosubtypic IFN-gamma-only-secreting effector memory T cells in pandemic H1N1 naive adults. Eur J Immunol 2012, [July 10].
29. Epstein S.L. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006, 193(January (1)):49-53.
30. Liem N.T., Tung C.V., Hien N.D., Hien T.T., Chau N.Q., Long H.T., et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009, 48(June (12)):1639-1646.
31. Bennink J.R., Yewdell J.W., Smith G.L., Moss B. Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled. J Virol 1987, 61(April (4)):1098-1102.
32. Subbarao K., Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat Rev 2007, 7(April (4)):267-278.
33. Sandbulte M.R., Jimenez G.S., Boon A.C., Smith L.R., Treanor J.J., Webby R.J. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007, 4(February (2)). e59.
34. Zebedee S.L., Lamb R.A. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 1988, 62(August (8)):2762-2772.
35. Treanor J.J., Tierney E.L., Zebedee S.L., Lamb R.A., Murphy B.R. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 1990, 64(March (3)):1375-1377.